Pages that link to "Q38318241"
Jump to navigation
Jump to search
The following pages link to Yin Yang 1 promotes hepatic steatosis through repression of farnesoid X receptor in obese mice. (Q38318241):
Displaying 26 items.
- Contributions of metabolic dysregulation and inflammation to nonalcoholic steatohepatitis, hepatic fibrosis, and cancer (Q26992106) (← links)
- Farnesoid X receptor: a master regulator of hepatic triglyceride and glucose homeostasis (Q28253815) (← links)
- Periostin promotes liver steatosis and hypertriglyceridemia through downregulation of PPARα. (Q33944254) (← links)
- Farnesoid X receptor inhibits LNcaP cell proliferation via the upregulation of PTEN (Q34119752) (← links)
- Recent insights into farnesoid X receptor in non-alcoholic fatty liver disease (Q34303001) (← links)
- FXR agonist GW4064 alleviates endotoxin-induced hepatic inflammation by repressing macrophage activation (Q34366966) (← links)
- Interleukin-18 Down-Regulates Multidrug Resistance-Associated Protein 2 Expression through Farnesoid X Receptor Associated with Nuclear Factor Kappa B and Yin Yang 1 in Human Hepatoma HepG2 Cells (Q35751457) (← links)
- Selective targeting of nuclear receptor FXR by avermectin analogues with therapeutic effects on nonalcoholic fatty liver disease (Q36333338) (← links)
- Calpain 2-mediated autophagy defect increases susceptibility of fatty livers to ischemia-reperfusion injury (Q36866407) (← links)
- MicroRNA-124 promotes hepatic triglyceride accumulation through targeting tribbles homolog 3. (Q37413876) (← links)
- Decreased genetic dosage of hepatic Yin Yang 1 causes diabetic-like symptoms. (Q37610126) (← links)
- FXR agonists as therapeutic agents for non-alcoholic fatty liver disease (Q38359118) (← links)
- The progress and challenges in metabolic research in China. (Q38376393) (← links)
- Mechanistic insight into nuclear receptor-mediated regulation of bile acid metabolism and lipid homeostasis by grape seed procyanidin extract (GSPE). (Q38770951) (← links)
- MicroRNA-92 promotes gastric cancer cell proliferation and invasion through targeting FXR. (Q41412793) (← links)
- Bioenergetic cues shift FXR splicing towards FXRα2 to modulate hepatic lipolysis and fatty acid metabolism (Q41974559) (← links)
- miR199a-5p inhibits hepatic insulin sensitivity via suppression of ATG14-mediated autophagy (Q51763083) (← links)
- Pharmacological induction of hypoxia-inducible transcription factor ARNT attenuates chronic kidney failure. (Q52319052) (← links)
- Hepatic expression of Yin Yang 1 (YY1) is associated with the non-alcoholic fatty liver disease (NAFLD) progression in patients undergoing bariatric surgery (Q57034320) (← links)
- Proteome-wide analysis of USP14 substrates revealed its role in hepatosteatosis via stabilization of FASN (Q59133408) (← links)
- Endocrine-Mediated Mechanisms of Metabolic Disruption and New Approaches to Examine the Public Health Threat (Q64241149) (← links)
- N6 -methyladenosine Reader Protein Ythdc2 Suppresses Liver Steatosis via Regulation of mRNA Stability of Lipogenic Genes (Q90160945) (← links)
- Myofibroblast-specific YY1 promotes liver fibrosis (Q91991242) (← links)
- Intestinal microbiome and NAFLD: molecular insights and therapeutic perspectives (Q92032230) (← links)
- Single-nucleotide polymorphism rs731384 is associated with plasma lipid levels and the risk of coronary artery disease in Chinese populations (Q93079090) (← links)
- Maternal glucose homeostasis is impaired in mouse models of gestational cholestasis (Q97529404) (← links)